Pulmonary and Functional Rehabilitation Improves Functional Capacity, Pulmonary Function and Respiratory Muscle Strength in Post COVID-19 Patients: Pilot Clinical Trial
Open Access
- 12 November 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 19 (22) , 14899
Abstract
Background: Patients affected by COVID-19 may develop an impaired lung function, with reduced lung capacities and volumes, respiratory muscle weakness, changes in radiographic and tomographic findings, limitations in exercising, decreased functional capacity, depression, anxiety and reduced quality of life. Thus, we aimed to analyze the effects of a pulmonary and functional rehabilitation program on the functional capacity, lung function and respiratory muscle strength in patients who were affected by COVID-19 syndrome. Methods: This is a pilot clinical trial, composed of post-COVID-19 patients with mild, moderate or severe involvement, in which, they underwent a pulmonary and functional rehabilitation program. Patients were evaluated for functional capacity by the 6 min walk test, pulmonary function by spirometry, respiratory muscle strength by manovacuometry, handgrip strength by dynamometry, quality of life by the COPD Assessment Test and functional status by the PCFS. After the initial assessments, the patients performed the rehabilitation protocol in 16 sessions (inspiratory muscle training, aerobic exercise and peripheral muscle strength) and, at the end, they were evaluated again. Results: A total of 29 patients completed the program (12.7 ± 2.7 sessions). The functional capacity increased in meters walked from 326.3 ± 140.6 to 445.4 ± 151.1 (p < 0.001), with an increase in the predicted value from 59.7% to 82.6% (p < 0.001). The lung function increased in liters from 2.9 ± 0.8 to 3.2 ± 0.8 (p = 0.004) for forced vital capacity and from 2.5 ± 0.7 to 2.7 ± 0.7 (p = 0.001) for forced expiratory volume in the first second. The respiratory muscle strength increased in cmH2O from 101.4 ± 46.3 to 115.8 ± 38.3 (p = 0.117) for inspiratory pressure and from 85.8 ± 32.8 to 106.7 ± 36.8 (p < 0.001) for expiratory pressure. Conclusions: The pulmonary and functional rehabilitation program provided an improvement in the functional capacity, pulmonary function and respiratory muscle strength in post-COVID-19 patients, restoring their quality of life.Keywords
This publication has 39 references indexed in Scilit:
- Teste de caminhada de seis minutos: valores de referência para adultos saudáveis no BrasilJornal Brasileiro de Pneumologia, 2011
- Creating scenarios of the impact of copd and their relationship to copd assessment test (CAT™) scoresBMC Pulmonary Medicine, 2011
- Efeitos do treinamento muscular inspiratório nos pacientes em hemodiáliseBrazilian Journal of Nephrology, 2011
- Teste de caminhada de seis minutos: uma ferramenta valiosa na avaliação do comprometimento pulmonarJornal Brasileiro de Pneumologia, 2011
- Addition of inspiratory muscle training to aerobic training improves cardiorespiratory responses to exercise in patients with heart failure and inspiratory muscle weaknessAmerican Heart Journal, 2009
- Development and first validation of the COPD Assessment TestEuropean Respiratory Journal, 2009
- Standardisation of spirometryEuropean Respiratory Journal, 2005
- A eficácia da reabilitação pulmonar na capacidade de exercício, força da musculatura inspiratória e qualidade de vida de portadores de doença pulmonar obstrutiva crônicaJornal Brasileiro de Pneumologia, 2005
- Measuring grip strength in normal adults: Reference ranges and a comparison of electronic and hydraulic instrumentsThe Journal of Hand Surgery, 2004
- Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax, 1999